., Nizamuddin. “Effect of SGLT2 Inhibitor (Empagliflozin) on HbA1c in Most Prevalent Age Group of Type 2 Diabetic Patients”. Translated byFahad Naim, Awais Naeem, Irum Mehmood, Samiullah ., and Tahira Abrar. International Journal of Pathology 20, no. 4 (March 10, 2023): 178–181. Accessed May 6, 2024. https://jpathology.com/index.php/OJS/article/view/802.